Arkas Pharma Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Endoglim Trio Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Endoglim Trio Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Endoglim Trio Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Endoglim Trio Tablet.
Endoglim Trio Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Endoglim Trio Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Endoglim Trio Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Endoglim Trio Tablet is a combination of three medicines: Glimepiride, Metformin, and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin decreases glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that reduces postprandial (after meals) glucose levels. This combination is not indicated for treating Type 1 DM.
Common side effects of Endoglim Trio Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Endoglim Trio Tablet is contraindicated in patients with known allergies to any of the ingredients or excipients. It should also be avoided in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
No, combining Endoglim Trio Tablet with alcohol is not advised as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Endoglim Trio Tablet can potentially cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely to occur if you miss meals, drink alcohol excessively, over-exercise, or use other antidiabetic medication simultaneously. Regular blood sugar monitoring is essential.
Store Endoglim Trio Tablet in its original packaging, tightly closed. Follow the instructions on the label regarding storage conditions. Do not dispose of unused medication. Ensure pets, children, and other people do not access this medicine.